E Kalbe

Summary

Affiliation: Max-Planck-Institute for Neurological Research
Country: Germany

Publications

  1. ncbi [Number processing and acalculia in dementia]
    E Kalbe
    Max Planck Institut für neurologische Forschung Gleueler Str 50 50931 Köln, Germany
    Z Gerontol Geriatr 35:88-101. 2002
  2. ncbi A new test battery to assess aphasic disturbances and associated cognitive dysfunctions -- German normative data on the aphasia check list
    Elke Kalbe
    Max Planck Institute for Neurological Research, Cologne, Germany
    J Clin Exp Neuropsychol 27:779-94. 2005
  3. ncbi The Rapid Dementia Screening Test (RDST): a new economical tool for detecting possible patients with dementia
    Elke Kalbe
    Max Planck Institute for Neurological Research, Cologne, Germany
    Dement Geriatr Cogn Disord 16:193-9. 2003
  4. ncbi Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment
    E Kalbe
    Department of Neurology, University Hospital, and Max Planck Institute for Neurological Research, Cologne, Germany
    Dement Geriatr Cogn Disord 19:349-56. 2005
  5. ncbi DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia
    E Kalbe
    Max Planck Institute for Neurological Research, Cologne, Germany
    Int J Geriatr Psychiatry 19:136-43. 2004
  6. ncbi Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
    J C Klein
    Department of Neurology, Goethe University, Frankfurt am Main, Germany
    Neurology 74:885-92. 2010
  7. ncbi Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease
    E Kalbe
    Department of Neurology, University of Cologne, Germany
    Neurology 72:42-9. 2009
  8. ncbi Learning face-name associations and the effect of age and performance: a PET activation study
    K Herholz
    Max Planck Institut für neurologische Forschung and Neurologische Universitätsklinik, Gleuler Str 50, D 50931, Cologne, Germany
    Neuropsychologia 39:643-50. 2001
  9. ncbi CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease
    C Haense
    Max Planck Institute for Neurological Research, Cologne, Germany
    Eur J Neurol 15:1155-62. 2008
  10. ncbi Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways
    R Hilker
    Department of Neurology, University of Cologne, Cologne, Germany
    Neurology 65:1716-22. 2005

Detail Information

Publications30

  1. ncbi [Number processing and acalculia in dementia]
    E Kalbe
    Max Planck Institut für neurologische Forschung Gleueler Str 50 50931 Köln, Germany
    Z Gerontol Geriatr 35:88-101. 2002
    ....
  2. ncbi A new test battery to assess aphasic disturbances and associated cognitive dysfunctions -- German normative data on the aphasia check list
    Elke Kalbe
    Max Planck Institute for Neurological Research, Cologne, Germany
    J Clin Exp Neuropsychol 27:779-94. 2005
    ..The ACL cognition part revealed additional neuropsychological dysfunction in the aphasia group. We present the patterns of these dysfunctions and their correlations with language deficits...
  3. ncbi The Rapid Dementia Screening Test (RDST): a new economical tool for detecting possible patients with dementia
    Elke Kalbe
    Max Planck Institute for Neurological Research, Cologne, Germany
    Dement Geriatr Cogn Disord 16:193-9. 2003
    ..The RDST is thus an economical tool for detecting demented patients by general practitioners...
  4. ncbi Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment
    E Kalbe
    Department of Neurology, University Hospital, and Max Planck Institute for Neurological Research, Cologne, Germany
    Dement Geriatr Cogn Disord 19:349-56. 2005
    ..To study awareness of cognitive dysfunction in patients with very mild Alzheimer's disease (AD) and subjects with mild cognitive impairment (MCI)...
  5. ncbi DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia
    E Kalbe
    Max Planck Institute for Neurological Research, Cologne, Germany
    Int J Geriatr Psychiatry 19:136-43. 2004
    ..To design a new, highly sensitive psychometric screening to identify patients with mild cognitive impairment (MCI) and patients with dementia in the early stages of the disease...
  6. ncbi Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
    J C Klein
    Department of Neurology, Goethe University, Frankfurt am Main, Germany
    Neurology 74:885-92. 2010
    ..Whether both are distinct disease entities is an ongoing controversy. Therefore, we directly compared patients with DLB and PDD with multitracer PET...
  7. ncbi Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease
    E Kalbe
    Department of Neurology, University of Cologne, Germany
    Neurology 72:42-9. 2009
    ..To investigate the underlying pathomechanisms, we correlated alterations of cognitive test performance and changes of neuronal energy metabolism in frontal basal ganglia projection areas under bilateral STN stimulation...
  8. ncbi Learning face-name associations and the effect of age and performance: a PET activation study
    K Herholz
    Max Planck Institut für neurologische Forschung and Neurologische Universitätsklinik, Gleuler Str 50, D 50931, Cologne, Germany
    Neuropsychologia 39:643-50. 2001
    ..Learning is further mediated by a predominantly left-hemispheric network including inferior temporal and orbitofrontal cortex...
  9. ncbi CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease
    C Haense
    Max Planck Institute for Neurological Research, Cologne, Germany
    Eur J Neurol 15:1155-62. 2008
    ....
  10. ncbi Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways
    R Hilker
    Department of Neurology, University of Cologne, Cologne, Germany
    Neurology 65:1716-22. 2005
    ..To assess neurochemical deficits in patients with Parkinson disease (PD) associated dementia (PDD) in vivo...
  11. ncbi Neuropsychological and neural correlates of autobiographical deficits in a mother who killed her children
    E Kalbe
    Department of Neurology, University Clinic Cologne, Cologne, Germany
    Neurocase 14:15-28. 2008
    ..Furthermore, they indicate that beliefs or prejudices may have a major impact on the brain's processing of the personal past...
  12. ncbi Elevated emotional reactivity in affective but not cognitive components of theory of mind: a psychophysiological study
    E Kalbe
    Department of Neurology, University of Cologne, Germany
    J Neuropsychol 1:27-38. 2007
    ..We discuss the possible underlying mechanisms for these differential psychophysiological correlates of affective and cognitive ToM processing, and suggest further investigations especially in clinical populations...
  13. ncbi Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
    K Herholz
    University Cologne, Neurological Clinic and Max Planck Institute for Neurological Research, 50931 Koln, Germany
    Neuroimage 17:302-16. 2002
    ..Ventromedial frontal cortex was also abnormal. In conclusion, automated analysis of multicenter FDG PET is feasible, provides insights into AD pathophysiology, and can be used potentially as a sensitive biomarker for early AD diagnosis...
  14. ncbi In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease
    K Herholz
    Department of Neurology, University Cologne, and Max Planck Institute for Neurological Research, Cologne, Germany
    Neuroimage 21:136-43. 2004
    ..The results support the concept that neocortical and amygdaloid functional changes of the cholinergic system are an early and leading event in AD, rather than the consequence of neurodegeneration of basal nuclei...
  15. ncbi Introducing MASC: a movie for the assessment of social cognition
    Isabel Dziobek
    Center for Brain Health, New York University School of Medicine, New York, NY, USA
    J Autism Dev Disord 36:623-36. 2006
    ..Issues pertaining to the multidimensionality of the social cognition construct are discussed...
  16. ncbi Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument
    Elke Kalbe
    Department of Neurology, University Hospital, University of Cologne, Germany
    Parkinsonism Relat Disord 14:93-101. 2008
    ..The mood questionnaire also had high sensitivity and specificity. We conclude that the PANDA is an economical, easy-to-use and sensitive tool to detect neuropsychological dysfunctions in PD patients in clinical practice...
  17. ncbi Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
    Lisa Mosconi
    Center for Brain Health, New York University School of Medicine, New York, New York 10016, USA
    J Nucl Med 49:390-8. 2008
    ....
  18. ncbi Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease
    Davide Anchisi
    Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Milan, Italy
    Arch Neurol 62:1728-33. 2005
    ..CONCLUSION: These data provide evidence for clinical and functional heterogeneity among subjects with aMCI and suggest that 18FDG-PET findings combined with memory scores may be useful in predicting short-term conversion to AD...
  19. ncbi Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease
    Eric Salmon
    Cyclotron Research Centre, University of Liege, Liege, Belgium
    Hum Brain Mapp 27:588-97. 2006
    ....
  20. ncbi Two aspects of impaired consciousness in Alzheimer's disease
    Eric Salmon
    Cyclotron Research Centre and Department of Neurology, University of Liege, B35 Sart Tilman, B4000 Liege, Belgium
    Prog Brain Res 150:287-98. 2005
    ..g., the temporoparietal junction). We hypothesize that these patients are impaired in the ability to see themselves with a third-person perspective (i.e., being able to see themselves as other people see them)...
  21. ncbi Decision-making impairments in patients with pathological gambling
    Matthias Brand
    Department of Physiological Psychology, University of Bielefeld, P O Box 100131, 33501 Bielefeld, Germany
    Psychiatry Res 133:91-9. 2005
    ..Therefore, risky decisions of PG patients might be influenced by both dorsolateral prefrontal and orbitofrontal cortex dysfunctions...
  22. ncbi Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression
    Vjera A Holthoff
    Department of Psychiatry and Psychotherapy, Dresden University of Technology, Germany
    Biol Psychiatry 57:412-21. 2005
    ..CONCLUSIONS: These findings support the notion that different functional circuits underlie apathy and depression in early AD...
  23. ncbi Cerebral acetylcholine esterase activity in mild cognitive impairment
    Karl Herholz
    Department of Neurology, University of Cologne, Koln, Germany
    Neuroreport 16:1431-4. 2005
    ..These results suggest that low cortical acetylcholine esterase activity may be an indicator of impending dementia in patients with mild cognitive impairment...
  24. ncbi Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions
    Matthias Brand
    Department of Physiological Psychology, University of Bielefeld, Bielefeld, Germany
    Neuropsychology 19:267-77. 2005
    ..Results show that Korsakoff patients are strongly impaired in this explicit decision-making task and that these disturbances are correlated with specific executive functions...
  25. ncbi Cognitive estimation in patients with probable Alzheimer's disease and alcoholic Korsakoff patients
    Matthias Brand
    Department of Physiological Psychology, University of Bielefeld, PO Box 100131, Bielefeld 33501, Germany
    Neuropsychologia 41:575-84. 2003
    ....
  26. ncbi Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease
    Carsten Eggers
    Department of Neurology, University of Cologne, Germany
    Neurosci Lett 408:46-50. 2006
    ..041, p<0.05) in the ApoE4 negative group only. These results indicate that cortical AChE activity is relatively well preserved in ApoE4 carriers, either by preservation of its cellular expression or as AChE activity in amyloid plaques...
  27. ncbi Organic and psychogenic factors leading to executive dysfunctions in a patient suffering from surgery of a colloid cyst of the Foramen of Monro
    Matthias Brand
    Department of Physiological Psychology, University of Bielefeld, Bielefeld, Germany
    Neurocase 10:420-5. 2004
    ..The authors conclude that in this case decision-making deficits and executive dysfunctions are influenced by both organic and psychogenic factors...
  28. ncbi Decision-making impairments in patients with Parkinson's disease
    Matthias Brand
    Department of Physiological Psychology, University of Bielefeld, Bielefeld, Germany
    Behav Neurol 15:77-85. 2004
    ....
  29. ncbi Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia
    Eric Salmon
    The Cyclotron Research Center, University of Liege, 4000 Liege, Belgium
    Neuroimage 20:435-40. 2003
    ....
  30. ncbi Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease
    Ruediger Hilker
    Departments of Neurology and dagger Stereotaxy and Functional Neurosurgery, University Hospital, Cologne, Germany
    J Cereb Blood Flow Metab 24:7-16. 2004
    ..These data suggest an activating effect of DBS upon its target structures and confirm a central role of the STN in motor as well as associative, limbic, and cerebellar basal ganglia circuits...